ClinicalTrials.Veeva

Menu

The Nordic DeltaCon Trial for Displaced Proximal Humeral Fractures in Elderly

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Active, not recruiting

Conditions

Proximal Humeral Fracture

Treatments

Procedure: Operative treatment with Reversed Total Shoulder Prosthesis

Study type

Interventional

Funder types

Other

Identifiers

NCT03531463
2018/476-D

Details and patient eligibility

About

The Nordic DeltaCon Trial is a prospective, single-blinded, randomized, controlled, multi-center and multi-national trial comparing reverse prosthesis and non-operative treatment in displaced proximal humerus fractures, in the elderly patients aged 65 to 85 years with displaced OTA/AO group B2 or C2 fractures (According to the new 2018 revision: AO/OTA (Orthopaedic Trauma Association) group 11-B1.1, 11-B1.2 and 11-C1.1, 11-C3.1. )

Full description

Single-blinded, multi-center, multi-national (Finland, Sweden, Denmark, Norway) Primary outcome in this study is QuickDASH (The short form of Disabilities of the arm, shoulder and hand) score measured at two years.

Secondary outcomes are QuickDASH at/after one, two (short term) and five years (medium term), general visual analog scale (VAS) for pain, Oxford shoulder score (OSS), Constant-score (CS), number of re-operations and complications. Quality of life is assessed with 15-D. Cost-effectiveness analysis will be performed after completion of the trial.

In addition to 2 years main outcome (short term) follow-up will continue to 5 years (medium term) and 10 years (long term). The power calculation is based on 2 years.

Enrollment

154 patients

Sex

All

Ages

65 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Low energy AO/OTA group 11-B1.1, 11-B1.2 and 11-C1.1, 11-C3.1. Both B and C type includes subgroups: Displaced [2], Impacted [3] or Non impacted [4] from the universal modifiers list.

Exclusion criteria

Radiographic Mal-inclination Less than; varus 30°or valgus 45° Less than 50% contact between head fragment and meta-/diaphysis Head split fractures with more than 10% of the articular surface in the main head fragment.

Head split fractures (group 11-C3.2 and 11-C3.3) with more than 10% of the articular surface in the main head fragment.

Dislocation or fracture-dislocation of the gleno-humeral joint Pathological fracture

General

  • Refuse to participate
  • Age under 65 years of age, or over 85 years of age
  • Serious poly-trauma or additional surgery
  • Non-independent, drug/alcohol abuse or institutionalized (low co-operation)
  • Contra-indications for surgery
  • Does not understand written and spoken guidance in local languages
  • Previous fracture with symptomatic sequelae in either shoulder
  • Patients living outside the hospital's catchment area

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

154 participants in 2 patient groups

Operative treatment
Active Comparator group
Description:
Operative treatment of the displaced proximal humeral fracture with a reversed total shoulder prothesis (Delta prosthesis) using a stadardized deltopectoral approach, bone block grafting and thread cerclages of the tubercles. Rehabilitation with standardized physiotherapy guideline and self exercise protocol
Treatment:
Procedure: Operative treatment with Reversed Total Shoulder Prosthesis
Non-Operative treatment
No Intervention group
Description:
Rehabilitation with standardized physiotherapy guideline and self exercise protocol

Trial contacts and locations

3

Loading...

Central trial contact

Tore Fjalestad, MD, PhD; Antti Launonen, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems